Strides Pharma Science Ltd Board of Directors
Board of Directors at Strides Pharma Science Ltd
Director (Business Developmnt)
Non-Exec. & Independent Dir.
Executive Chairman & M.D.
Managing Director & Group CEO
Non-Exec. & Independent Dir.
Key Highlights
- Arun Kumar continues to serve as the Chairman & Non Executive Dir. in 2026, maintaining the same position as in the previous year.
- Badree Komandur joins the board as Group CEO & Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- VENKATA SEETHARAMA RAJU PAKALAPATI joins the board as Executive Director & COO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kausalya Santhanam continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
- Mukta Malik Arora continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
Strides Pharma Science Ltd
NSE: STAR
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 1087.75 |
| 05 Oct 2026 | 1085.85 |
| 01 Oct 2026 | 1082.95 |
| 30 Sep 2026 | 1117.85 |
| 29 Sep 2026 | 1170.5 |
| 28 Sep 2026 | 1151.35 |
| 25 Sep 2026 | 1184.2 |
| 24 Sep 2026 | 1202.7 |
| 23 Sep 2026 | 1225.35 |
| 22 Sep 2026 | 1215.55 |
Company Fundamentals for Strides Pharma Science Ltd
Market Cap
10,026 Cr
EPS
62.6
P/E Ratio (TTM)
17.4
P/B Ratio (TTM)
3.2
Day’s High
1096.65
Day’s Low
1075.0
DTE
0.6
ROE
17.9
52 Week High
1260.1
52 Week Low
769.6
ROCE
17.3
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24
